Shift4 Payments Is On Sale And I Can't Stop Buying

Shift4 reported Q3 revenue of $589.2M (beat $584.9M) driven by the completed Global Blue acquisition, with consolidated YoY revenue up 62% and organic payments revenue (“sit-on-our-hands”) at $433M, +19% YoY. Adjusted EBITDA hit a record $292.1M and net cash from operations was $171.8M (~30% conversion); management raised FY revenue guidance to $1.98B–$2.02B (+46–49% YoY) and expects ~50% adjusted FCF conversion. The balance sheet shows cash up but long-term debt roughly doubled to $4.02B with concentrated maturities in 2032–33 and near-term scheduled principal of $692.5M (2025), $10M (2026) and $642.5M (2027); author argues valuation (forward non‑GAAP P/E ~13.4; forward P/FCF ~9; EV/FCF ~16) is attractive despite leverage and competitive/consumer‑spend risks, recommending a long-term buy.

Analysis

Market structure: The combination of payments scale plus Global Blue tilts winners to integrated omni‑commerce processors and travel‑linked payment ecosystems — merchants with cross‑border volumes and acquirers offering value‑added refunds gain share; pure POS incumbents (e.g., TOST) that lack international VAT/returns services risk margin compression. Pricing power will be uneven: processing yields protected in enterprise verticals but face pressure in SME retail as interchange and competition normalize; expect 3–5% pressure on blended take‑rates over 12–24 months in lower‑value segments.

Risk assessment: The dominant tail risk is a refinancing shock from concentrated principal in 2025–27 paired with elevated net leverage — a 200–300bp sustained rate shock or EBITDA miss (>20% below guidance) could force equity dilution or asset sales within 6–18 months. Operational integration of cross‑border flows and fraud controls is a second tail: a material charge or regulatory action (e.g., EU travel‑retail scrutiny) within 3–12 months would compress multiples sharply.

Trade implications: Favor a controlled equity overweight in FOUR sized 2–4% of portfolio with a 6–12 month horizon, hedged by a protective collar (buy 12‑month 25% OTM puts, sell 12‑month 40% OTM calls). Pair trade: long FOUR vs short TOST (size ratio 1:0.6) to extract relative margin/valuation repricing; avoid buying corporate paper — limit bond exposure until 2027 maturities are refinanced or net leverage <6x.

Contrarian angles: The market understates refinancing execution risk and overstates stable FCF conversion — cheap multiples (P/FCF~9) ignore potential >20% dilution in downside scenarios. Historical parallels: payments rollups (e.g., First Data era) often saw equity recoveries cut by covenant‑driven restructurings; if management achieves 45–50% FCF conversion for 2 consecutive quarters, upside re‑rating to EV/FCF <12x is plausible within 9–15 months.

Key Decisions for Investors

• Establish a 2–4% long position in FOUR (Shift4) using equity, financed via a collar: buy shares and simultaneously buy 12‑month 25% OTM puts and sell 12‑month 40% OTM calls to cap upside and limit downside through next year; reassess at 6 months or if FCF conversion <30% over two consecutive quarters.
• Implement a relative value pair: long FOUR and short TOST at a 1:0.6 notional ratio (reduce gross exposure by hedging sector beta); target capture of margin expansion vs competitive share gains over 6–12 months, close if FOUR underperforms by >15% vs TOST in 60 days.
• Avoid buying FOUR corporate bonds or new issue paper until at least one of the key maturities (2025/2027) is refinanced or net leverage falls below 6x; instead consider buying short‑dated protection (12–24 month CDS) if available as a low‑cost hedge against refinancing/default risk.
• Set hard risk triggers: trim or exit equity position if (a) net leverage >8x EBITDA, (b) organic payments growth falls below +5% YoY, or (c) quarterly FCF conversion <30% — these indicate material downside or dilution within 3–9 months.